Catalyst Wire Dossier Catalyst Wire Dossier

KAITLIB FE

Norethindrone and Ethinyl Estradiol · Lupin Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KAITLIB FE, covering 2015-12-17 to 2024-05-06. Get the full timeline:

Most recent: FDA Approved: KAITLIB FE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

See pricing